Lymphocyte subset ratios and factor VIII usage in haemophilia

Area of Science:

• Hematology
• Immunology
• Pediatrics

Background:

• Severe hemophilia A requires factor replacement therapy.
• Factor concentrates can impact hematological and immunological parameters.
• Potential long-term sequelae of concentrate use are not fully understood.

Purpose of the Study:

• To investigate the relationship between factor VIII concentrate quantity and hematological/immunological parameters in boys with severe hemophilia A.
• To compare these parameters with children having other bleeding disorders.
• To assess potential associations with acquired immune deficiency syndrome (AIDS)-like abnormalities.

Main Methods:

• Retrospective analysis of treatment and laboratory data.
• Correlation analysis between factor VIII concentrate dosage (U/year) and cell counts (WBC, lymphocytes, platelets).
• Assessment of T lymphocyte subsets (T4:T8 ratio) and immunoglobulins.

Main Results:

• Inverse correlation found between factor VIII concentrate quantity and total white cell, lymphocyte, and platelet counts.
• 49% of severe hemophilia A patients showed inverted T4:T8 ratios; 24% had thrombocytopenia.
• High factor VIII concentrate use (>25,000 U/year) linked to low platelets, lymphocytes, inverted T4:T8 ratios, and hypergammaglobulinaemia.
• Patients treated with cryoprecipitate or prothrombin complex concentrates had normal parameters.

Conclusions:

• High factor VIII concentrate usage in severe hemophilia A is associated with significant hematological and immunological abnormalities.
• These abnormalities resemble those seen in AIDS patients.
• Further prospective studies are needed to evaluate long-term risks of factor concentrate usage, including potential links to AIDS.